Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13461| Title: | Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy |
| Authors: | Gaikwad, Anil Bhanudas |
| Keywords: | Pharmacy Diabetic nephropathy Renin-angiotensin system (RAS) Diabetic nephropathy (DN) |
| Issue Date: | Mar-2019 |
| Publisher: | Elsevier |
| Abstract: | Renin-angiotensin system (RAS) and natriuretic peptides system (NPS) perturbations govern the development of diabetic nephropathy (DN). Hence, in search of a novel therapy against DN, present study targeted both, NPS and RAS simultaneously using a neprilysin inhibitor (NEPi) in combination with either angiotensin receptor blocker (ARB) or angiotensin-converting enzyme 2 (ACE2) activator. |
| URI: | https://www.sciencedirect.com/science/article/abs/pii/S0024320519301171 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13461 |
| Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.